Sino Biopharmaceutical Limited has notified the market that its board of directors will convene on 19 August 2026. The meeting agenda includes:

• Approval for publication of the unaudited interim results covering the six months ended 30 June 2026. • Consideration of an interim dividend payout for the period, subject to board approval.

The board currently comprises five executive directors—Tse Theresa Y Y, Tse Ping, Cheng Cheung Ling, Tse Eric S Y and Tse Hsin—and six independent non-executive directors—Lu Zhengfei, Lu Hong, Zhang Lu Fu, Li Kwok Tung Donald, Chen Lieping and Lu Bai.

The company made the announcement in Hong Kong on 6 August 2026.